BioSpace News Archive

Press Releases

Cantargia Highlights Preclinical Data at AACR Supporting Nadunolimab in Combination with RAS Inhibition in PDAC

September 30, 2026
·
4 min read
Press Releases

Roche launches newborn screening test for three severe genetic conditions

September 30, 2026
·
6 min read
Press Releases

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress

September 30, 2026
·
29 min read
Press Releases

Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill

September 30, 2026
·
19 min read
Press Releases

Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis

September 30, 2026
·
13 min read
Press Releases

EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis

September 30, 2026
·
9 min read
Press Releases

Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026

September 30, 2026
·
16 min read
Press Releases

AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026

September 30, 2026
·
7 min read
Press Releases

AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness

September 30, 2026
·
7 min read
Press Releases

Faron Pharmaceuticals Ltd: Convertible Bond Amortization Payment Deferred by Mutual Agreement With HCM

September 30, 2026
·
4 min read